CMS verifies dementia care quality in the GUIDE Model through a published measurement manual, not through promises alone. The agency's GUIDE Performance Measurement Manual, version 3.0, finalizes how Dementia Care Programs are scored for Performance Year 2025 and sets rules for 2026, and families can check both the measures and their own provider's participation using public documents rather than guesswork.
GUIDE stands for Guiding an Improved Dementia Experience, an eight-year nationwide demonstration from the CMS Innovation Center for Medicare beneficiaries with dementia. It began July 1, 2024, and pays participating Dementia Care Programs a monthly fee to run 24/7 support lines, assign care navigators, and train caregivers, according to CMS's July 2024 announcement. What changed for 2026 is specific and verifiable: new measure names, a new data source for one measure, and a new measure altogether.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Official resources:
- Read the official guidance from CMS — Use this primary source to verify the official guidance.
- Read the official guidance from CMS — Use this primary source to verify the official guidance.
Table of Contents
- What Changed in the 2026 Quality Measures
- Confirming Whether a Specific Provider Participates
- The Respite Benefit and Why the Measures Carry Financial Weight
- How to Verify Any of This Locally
- Frequently Asked Questions
What Changed in the 2026 Quality Measures
CMS's GUIDE Performance Measurement Manual, version 3.0, dated May 18, 2026, moved one long-standing measure onto claims data instead of self-reported chart abstraction. The "Use of High-Risk Medications in Older Adults" measure, previously tracked through a chart-abstracted version called HRRx, becomes a claims-based measure called DAE ahead of the 2026 performance period, according to CMS's GUIDE Performance Measurement Manual. That shift cuts the manual data entry Dementia Care Programs previously had to perform for this measure. The same manual renamed the quality-of-life measure to "Quality of Life for Patients Living with Dementia" (QoL-PLWD) and added risk adjustment to it, and it replaced the prior Caregiver Burden measure with a new specification called "Caregiver-Reported Impact in Dementia" (CID), per the same CMS manual.
Families who ask a provider about caregiver support outcomes should expect this newer CID terminology going forward rather than the older burden language. NCQA, the organization that writes technical specifications for several CMS Innovation Center measures, confirms the expanded 2026 measure set from the outside. Its measure-specification hub lists two GUIDE measures for 2026 — the claims-based high-risk-medication measure (DAE) and a new measure called Potentially Harmful Drug-Disease Interactions in Older Adults (DDE) — compared with only the DAE measure in 2024 and 2025, according to NCQA's measure-specification hub. The new DDE measure means a second medication-safety check enters the model's scoring for the first time in 2026.
Confirming Whether a Specific Provider Participates
Not every memory care clinic, health system, or hospice is enrolled in GUIDE, and enrollment is the first thing to confirm before relying on any of its benefits. As of 2026 the model has 330 active participants: 89 in the original "established" program track and 241 in the newer "new" program track, a figure CMS itself publishes rather than estimates, according to CMS GUIDE participant data via LeadingAge NY.
Families can check whether a specific organization is on that list by consulting CMS's published GUIDE Participant List spreadsheet. Participation alone does not enroll a beneficiary automatically — a beneficiary must separately consent to being aligned with that participant's Dementia Care Program before GUIDE services begin, per CMS's GUIDE Model documentation via LeadingAge NY. That means two separate facts to verify: whether the organization appears on the participant list, and whether consent paperwork for alignment has actually been completed.
- Ask the provider directly whether they are a GUIDE participant and in which track (established or new).
- Request confirmation that the beneficiary has been formally aligned, since appearing on a provider's patient roster is not the same as GUIDE alignment.
- Keep a copy of any consent document signed for alignment, since this is the record that triggers GUIDE services and billing.
The Respite Benefit and Why the Measures Carry Financial Weight
GUIDE funds an annual per-beneficiary respite-care benefit with no cost-sharing, available to enrollees with moderate-to-severe dementia who have an unpaid caregiver. The original $2,500 annual cap was raised to $2,563 per patient for Performance Year 2025, according to CMS's GUIDE Participant Model Incentives Fact Sheet. This benefit exists independently of a provider's quality scores, but families should know it has a yearly cap tied to a specific performance year, so it is worth asking which year's cap currently applies. The quality measures described above are not simply tracked for reporting purposes — they affect what a Dementia Care Program is paid.
CMS ties part of each participant's monthly per-patient GUIDE payment to performance on the model's quality measures, along with total cost of care and long-term nursing-home-placement rates, according to CMS's GUIDE Payment Methodology Paper. Families cannot see the specific dollar amounts a provider earns or loses, since that detail is not made public, but they can confirm which measures apply to a given performance year by reading the public measurement manual itself. This matters practically because a provider's incentive to manage high-risk medications, limit avoidable nursing-home placement, and track caregiver-reported outcomes is now directly connected to its GUIDE payment. A family that understands the measures in Section 1 is reading the same scorecard CMS uses to adjust that payment.
How to Verify Any of This Locally
Verifying GUIDE status and measures does not require special access — every document involved is public. Start with the participant list, then move to the measurement manual, then confirm consent paperwork with the provider directly. Because CMS now labels performance years by calendar year under the version 3.0 manual, a family comparing information from an earlier source should confirm which performance year's rules that older source was describing, since measure names and data sources have changed between years.
- Check the current GUIDE Participant List, available through CMS and mirrored by LeadingAge NY, for the provider's name and program track.
- Read the relevant performance year's section of the GUIDE Performance Measurement Manual to see which measures (DAE, DDE, QoL-PLWD, CID) apply and how they are defined.
- Ask the provider in writing whether alignment consent has been signed, since this is the step that actually activates GUIDE services for a specific beneficiary.
- Ask about the current respite-benefit cap for the active performance year, since the cap amount can change between performance years.
- If a provider claims GUIDE participation but cannot confirm alignment or point to the respite benefit, treat that as a reason to ask more questions before assuming full GUIDE services are in place.
Frequently Asked Questions
Does every memory care provider automatically belong to the GUIDE Model?
No. As of 2026 only 330 organizations are active GUIDE participants, and families must check the published participant list to confirm a specific provider's status, per CMS GUIDE participant data via LeadingAge NY.
Did the medication-safety measure change for 2026?
Yes. It moved from a chart-abstracted measure (HRRx) to a claims-based measure (DAE), and a second claims-based measure for harmful drug-disease interactions (DDE) was added, according to CMS's manual and NCQA's specification hub.
Is signing up with a GUIDE participant enough to get services?
No. A beneficiary must separately consent to alignment with that participant's Dementia Care Program before GUIDE services begin, per CMS's GUIDE Model documentation.
You Might Also Like
- Diabetes in the 2026 WHO Dementia Guideline: How Adults in Midlife Can Build a Realistic Brain Health Plan
- Cognitive Training in the 2026 WHO Dementia Guideline: How Adults in Midlife Can Build a Realistic Brain Health Plan
- NHATS and NSOC Dementia Care Data Priorities in 2026: How Adults With Memory Concerns Can Avoid Overreading the Headline
